Advertisement
A vs ATR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Hold and ATR is a Buy.
Momentum Indicator for A turns positive, indicating new upward trend
A saw its Momentum Indicator move above the 0 level on November 06, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In 60 of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at 70%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +4.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where A advanced for three days, in 187 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
The Aroon Indicator entered an Uptrend today. In 143 of 209 cases where A Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.
Bearish Trend Analysis
The 10-day RSI Indicator for A moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 17 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 61%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 68 cases where A's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 65%.
The Moving Average Convergence Divergence Histogram (MACD) for A turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 28 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 64%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where A declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
A broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 9 (best 1 - 100 worst), indicating outstanding price growth. A’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.692) is normal, around the industry mean (67.298). P/E Ratio (34.334) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (1.447) is also within normal values, averaging (3.473). Dividend Yield (0.006) settles around the average of (0.002) among similar stocks. P/S Ratio (5.910) is also within normal values, averaging (9.775).
The Tickeron PE Growth Rating for this company is 44 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 64 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock slightly better than average.
ATR in upward trend: 10-day moving average crossed above 50-day moving average on October 28, 2026
The 10-day moving average for ATR crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on ATR as a result. In 48 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 59%.
The Moving Average Convergence Divergence (MACD) for ATR just turned positive on October 14, 2026. Looking at past instances where ATR's MACD turned positive, the stock continued to rise in 37 of 57 cases over the following month. The odds of a continued upward trend are 65%.
ATR moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
The 50-day moving average for ATR moved above the 200-day moving average on November 10, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +10.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where ATR advanced for three days, in 179 of 335 cases, the price rose further within the following month. The odds of a continued upward trend are 53%.
The Aroon Indicator entered an Uptrend today. In 120 of 222 cases where ATR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 17 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
ATR broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. ATR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 71 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Valuation Rating of 73 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.447) is normal, around the industry mean (4.964). P/E Ratio (25.446) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (2.595) is also within normal values, averaging (4.143). Dividend Yield (0.013) settles around the average of (0.005) among similar stocks. P/S Ratio (2.072) is also within normal values, averaging (56.876).
A | ATR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 84 | 39 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 24 Undervalued | 73 Overvalued | |
PROFIT vs RISK RATING 1..100 | 64 | 71 | |
SMR RATING 1..100 | 45 | 59 | |
PRICE GROWTH RATING 1..100 | 9 | 39 | |
P/E GROWTH RATING 1..100 | 44 | 13 | |
SEASONALITY SCORE 1..100 | 50 | 11 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
A's Valuation (24) in the Biotechnology industry is somewhat better than the same rating for ATR (73) in the Containers Or Packaging industry. This means that A’s stock grew somewhat faster than ATR’s over the last 12 months.
A's Profit vs Risk Rating (64) in the Biotechnology industry is in the same range as ATR (71) in the Containers Or Packaging industry. This means that A’s stock grew similarly to ATR’s over the last 12 months.
A's SMR Rating (45) in the Biotechnology industry is in the same range as ATR (59) in the Containers Or Packaging industry. This means that A’s stock grew similarly to ATR’s over the last 12 months.
A's Price Growth Rating (9) in the Biotechnology industry is in the same range as ATR (39) in the Containers Or Packaging industry. This means that A’s stock grew similarly to ATR’s over the last 12 months.
ATR's P/E Growth Rating (13) in the Containers Or Packaging industry is in the same range as A (44) in the Biotechnology industry. This means that ATR’s stock grew similarly to A’s over the last 12 months.
| A | ATR | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 61% | 1 day ago 33% |
| Stochastic ODDS (%) | 1 day ago 65% | 1 day ago 41% |
| Momentum ODDS (%) | 1 day ago 70% | 1 day ago 59% |
| MACD ODDS (%) | 1 day ago 64% | 1 day ago 65% |
| TrendWeek ODDS (%) | 1 day ago 64% | 1 day ago 52% |
| TrendMonth ODDS (%) | 1 day ago 63% | 1 day ago 52% |
| Advances ODDS (%) | 3 days ago 62% | 10 days ago 53% |
| Declines ODDS (%) | 10 days ago 63% | 6 days ago 51% |
| BollingerBands ODDS (%) | 1 day ago 67% | 1 day ago 49% |
| Aroon ODDS (%) | 1 day ago 68% | 1 day ago 54% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
A’s FA Score shows that 2 FA rating(s) are green while ATR’s FA Score has 1 green FA rating(s).
- A’s FA Score: 2 green, 3 red.
- ATR’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
A’s TA Score shows that 3 TA indicator(s) are bullish while ATR’s TA Score has 7 bullish TA indicator(s).
- A’s TA Score: 3 bullish, 5 bearish.
- ATR’s TA Score: 7 bullish, 4 bearish.
Price Growth
A (@Medical Specialties) experienced а +1.38% price change this week, while ATR (@Pharmaceuticals: Other) price change was +1.27% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -4.38%. For the same industry, the average monthly price growth was -4.35%, and the average quarterly price growth was +39.80%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.44%. For the same industry, the average monthly price growth was +4.11%, and the average quarterly price growth was +16.86%.
Reported Earning Dates
A is expected to report earnings on Nov 23, 2026.
ATR is expected to report earnings on Feb 18, 2027.
Industries' Descriptions
@Medical Specialties (-4.38% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Pharmaceuticals: Other (+4.44% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement
ATR and
Correlation & Price change
A.I.dvisor indicates that over the last year, ATR has been loosely correlated with SYK. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ATR jumps, then SYK could also see price increases.